Kurt F. Somerville’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$10.3M Buy
23,186
+310
+1% +$138K 1.74% 24
2025
Q1
$11.1M Buy
22,876
+2,484
+12% +$1.2M 1.93% 24
2024
Q4
$8.21M Buy
20,392
+3,748
+23% +$1.51M 1.38% 26
2024
Q3
$7.74M Buy
16,644
+4,546
+38% +$2.11M 1.25% 28
2024
Q2
$5.67M Buy
12,098
+7,300
+152% +$3.42M 0.96% 29
2024
Q1
$2.01M Buy
4,798
+2,623
+121% +$1.1M 0.34% 42
2023
Q4
$885K Buy
2,175
+750
+53% +$305K 0.17% 54
2023
Q3
$496K Sell
1,425
-75
-5% -$26.1K 0.1% 72
2023
Q2
$528K Hold
1,500
0.1% 72
2023
Q1
$473K Hold
1,500
0.09% 78
2022
Q4
$433K Hold
1,500
0.08% 82
2022
Q3
$434K Hold
1,500
0.09% 82
2022
Q2
$423K Hold
1,500
0.08% 85
2022
Q1
$391K Hold
1,500
0.06% 89
2021
Q4
$329K Hold
1,500
0.05% 105
2021
Q3
$272K Hold
1,500
0.04% 103
2021
Q2
$302K Hold
1,500
0.05% 97
2021
Q1
$322K Hold
1,500
0.05% 91
2020
Q4
$355K Hold
1,500
0.06% 86
2020
Q3
$408K Sell
1,500
-40
-3% -$10.9K 0.07% 81
2020
Q2
$447K Sell
1,540
-8
-0.5% -$2.32K 0.08% 80
2020
Q1
$368K Hold
1,548
0.08% 77
2019
Q4
$339K Hold
1,548
0.06% 78
2019
Q3
$262K Hold
1,548
0.05% 88
2019
Q2
$284K Hold
1,548
0.06% 85
2019
Q1
$285K Hold
1,548
0.06% 94
2018
Q4
$257K Hold
1,548
0.06% 94
2018
Q3
$298K Hold
1,548
0.06% 96
2018
Q2
$263K Hold
1,548
0.06% 93
2018
Q1
$252K Hold
1,548
0.06% 97
2017
Q4
$232K Hold
1,548
0.05% 101
2017
Q3
$235K Buy
+1,548
New +$235K 0.05% 98